Dna X SONM

NASDAQ SONM
$2.66 +0.53 (+30.81%)
As of: Nov 9, 2026 · 10:18 AM EST

Dna X (SONM) stock price is $2.66, up 30.81% on the day, as of Nov 9, 2026. It has a market cap of $3.59Mn, and is classified in the Crypto Exchanges industry (Financial Services sector).

Key Stats
Market Cap3.59 Mn
P/E-0.42
FCF (Yr)-5.47 Mn
ROA (Yr)21.04
EV to EBIT0.46
Net Income (Yr)5.09 Mn
Enterprise Value-1.94 Mn
Add ratio to table…

About

DNA X, Inc. provides crypto trading services to the public through its website www.dnax.us. The platform allows users to buy and sell cryptocurrencies using cash or cash equivalents. Users can also exchange one cryptocurrency for another directly on the site. New customers may create an account and begin trading immediately. The company offers tools for building automated trading strategies that execute when price ratios reach predefined levels. Users can view and duplicate…

Read more ↓
Sectors: Financial Services Technology Sector rationale The company's primary revenue is generated from commissions on cryptocurrency trades and planned interest-like fees from lending, which aligns with the 'Crypto Exchanges' and 'Specialty Finance' industries within Financial Services. A secondary sector of Technology is justified because the company develops and operates its own proprietary trading platform and custom software modifications as a core part of its business model. Industries: Crypto Exchanges Crypto Exchanges Primary DNA X operates a platform where users buy, sell, and exchange cryptocurrencies, generating revenue primarily from commissions charged on each trade. This matches the description of a crypto exchange and brokerage for digital assets. Blockchain Infrastructure Blockchain Infrastructure Secondary The company develops custom software modifications for its platform and provides tools for building and duplicating automated trading strategies, which constitutes blockchain-based trading infrastructure. Classified using BQ-MICS CIK: 0001178697

Product and Service Breakdown of Revenue (2024)

History

Geographical Breakdown of Revenue (2024)

History
Peer percentiles

How Dna X ranks

Ranked against the 110 companies in Capital Markets58 metrics · as of Nov 6, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −0.36xMedian 28.4x 8th
  • P/FCFNegative free cash flow −0.63xMedian 15.1x 2nd
  • P/Operating cash flow —Median 13.6x No data —
  • P/S 0.22xMedian 2.91x 87th
  • P/BNegative shareholder equity −2.78xMedian 2.32x Not meaningful —
  • P/Tangible bookNegative tangible equity −1.31xMedian 3.28x Not meaningful —
  • EV/EBITDA —Median 13.2x No data —
  • EV/EBITNegative EBIT −1.17xMedian 16.5x 7th
  • EV/Revenue 0.32xMedian 3.26x 89th
  • EV/FCF —Median 18.3x No data —
  • EV/Operating cash flow —Median 17.0x No data —
  • PEG (3Y EPS CAGR)Negative earnings −0.05Median 0.47 Not meaningful —
Peer group

Peer Comparison

Companies in the Crypto Exchanges
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 CME Cme Group Inc. 108.68 Bn24.6215.593.43 Bn
2 BNY Bank of New York Mellon Corp 103.17 Bn16.404.7041.16 Bn
3 ICE Intercontinental Exchange, Inc. 97.77 Bn23.496.9623.30 Bn
4 HOOD Robinhood Markets, Inc. 76.27 Bn38.4415.012.66 Bn
5 NDAQ Nasdaq, Inc. 60.56 Bn29.066.628.74 Bn
6 STT State Street Corp 47.02 Bn13.633.03-
7 CBOE Cboe Global Markets, Inc. 36.97 Bn25.077.001.44 Bn
8 SONM DNA X, Inc. 0.00 Bn-0.420.230.00 Bn